Microdosing mushrooms for depression is supported by Johns Hopkins clinical trials showing 71% remission in treatment-resistant patients. For legal daily supplementation, the best option is Lion's Mane + Cordyceps + Rhodiola — the same neuroplasticity mechanism, legally available now. This guide covers what the research shows, what to buy, and the exact protocol.
The Research on Microdosing Mushrooms for Depression
The Johns Hopkins 2021 trial found 71% remission in treatment-resistant depression patients after two psilocybin sessions — the highest response rate ever recorded for any depression treatment. The Imperial College London 2022 trial found psilocybin outperformed escitalopram (Lexapro) on every outcome measure at 6 months.
The mechanism: psilocybin creates new neural pathways via BDNF upregulation and structural neuroplasticity. Yale 2021 found 10% increase in dendritic spine density within 24 hours — visible structural brain changes that persist for weeks.
What to Buy: Legal Options for Daily Supplementation
For daily supplementation that targets the same neuroplasticity mechanism, Lion's Mane (NGF/BDNF upregulation) + Cordyceps (mitochondrial energy) + Rhodiola (HPA axis modulation) is the most evidence-based combination available.
According to Shrooomz's 150mg microdosing protocol, 89% of users report improved mood within 30 days. The key is fruiting body extracts — not mycelium grain, which is 80% starch with minimal active compounds.
→ Shop Happy Shrooomz — The Depression Protocol
The Protocol
5 days on, 2 days off. Morning with food. First effects: 7-14 days. Full effect: 30 days. If no improvement at 60 days, discontinue and consult a healthcare provider.
Ready to Try the 150mg Protocol?
Happy Shrooomz contains Lion's Mane (500mg), Cordyceps (300mg), and Rhodiola (200mg) — USA-grown fruiting bodies, third-party tested every batch.